Annotation Detail for REG1A

Basic Information
Top
Desease ID | Desease Name |
---|
1832 | Congenital abnormality |
1847 | Alimentary system disease |
1730 | Disseminated cancer |
1943 | Adenocarcinoma |
2148 | Stomach disease |
2164 | Barrett's esophagus |
Desease Name |
---|
IMMUNE |
diabetes, type 2 |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of REG1A mRNA | affects expression | 16483693
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of REG1A mRNA | affects cotreatment|decreases expression | 17183730
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of REG1A mRNA | decreases expression | 16184548
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of REG1A mRNA | affects cotreatment|decreases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.11 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.35 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.19 | 18287403 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.15 | 18759972 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.96 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.90 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.98 | 19460635 15238991 17157402 18558336 18316065 16609825 18396377 17507914 17688650 18940202 19232924 20603192 18985861 18775368 18177632 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.24 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.63 | 8888407 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.55 | 12391285 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.82 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.91 | 16575769 17688650 8888407 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.25 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.51 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.71 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.64 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.11 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.96 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.86 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.69 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.72 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.61 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.64 | 8888407 18558336 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.19 | 16612254 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.20 | 17596541 16294345 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.98 | 17228818 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.47 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.45 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.35 | 17596541 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.37 | 16359493 8888407 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.46 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.26 | 12752131 11422049 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.64 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.99 | 15475178 14763951 3137016 1511512 11738929 17978042 16876388 11044598 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.09 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.26 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.96 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.15 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.20 | 8888407 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
5.16 | 18645019 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB03721 |
- |
O-Sialic Acid |
|
DB04522 |
- |
Phosphonoserine |
|